Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 573

1.

Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.

Heier JS, Topping TM, Baumann W, Dirks MS, Chern S.

Ophthalmology. 2000 Nov;107(11):2034-8;discussion 2039.

PMID:
11054327
2.

Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.

Weisz JM, Bressler NM, Bressler SB, Schachat AP.

Ophthalmology. 1999 Sep;106(9):1656-9.

PMID:
10485530
3.

Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.

Rho DS.

J Cataract Refract Surg. 2003 Dec;29(12):2378-84.

PMID:
14709300
4.

A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.

Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M; Acular LS for Cystoid Macular Edema (ACME) Study Group.

Am J Ophthalmol. 2008 Oct;146(4):554-560. doi: 10.1016/j.ajo.2008.04.036. Epub 2008 Jul 2.

PMID:
18599019
5.

Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.

Simone JN, Pendelton RA, Jenkins JE.

J Cataract Refract Surg. 1999 May;25(5):699-704.

PMID:
10330648
6.

Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone.

Singal N, Hopkins J.

Can J Ophthalmol. 2004 Apr;39(3):245-50.

PMID:
15180141
7.

Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.

Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE.

J Ocul Pharmacol Ther. 2014 Aug;30(6):495-501. doi: 10.1089/jop.2013.0214. Epub 2014 Apr 15.

PMID:
24735005
8.

Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A.

Ophthalmology. 2001 Feb;108(2):331-7.

PMID:
11158809
10.

Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.

Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT, Kratky V, ten Hove MW, Sharma S, El-Defrawy S.

J Cataract Refract Surg. 2008 Jan;34(1):64-9. doi: 10.1016/j.jcrs.2007.08.034.

PMID:
18165083
11.

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.

Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A.

Am J Ophthalmol. 1999 Mar;127(3):253-9.

PMID:
10088733
12.

Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment.

Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL.

J Cataract Refract Surg. 2007 Sep;33(9):1550-8.

PMID:
17720069
13.

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.

Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T.

J Cataract Refract Surg. 2006 Sep;32(9):1474-82.

PMID:
16931258
14.

Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone.

Abe T, Hayasaka S, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y.

J Cataract Refract Surg. 1999 Sep;25(9):1286-8.

PMID:
10476516
15.
16.

Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.

Brint SF, Cheetham JK, DeGryse R, Abel ML, Thompson VM, Rosenthal A.

J Cataract Refract Surg. 1999 Jan;25(1):41-9.

PMID:
9888075
17.

Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.

Warren KA, Fox JE.

Retina. 2008 Nov-Dec;28(10):1427-34. doi: 10.1097/IAE.0b013e31817e7ead.

PMID:
18664937
18.

Vitrectomy for chronic pseudophakic cystoid macular edema.

Pendergast SD, Margherio RR, Williams GA, Cox MS Jr.

Am J Ophthalmol. 1999 Sep;128(3):317-23.

PMID:
10511026
20.

Supplemental Content

Support Center